Association of sex hormones and glucose metabolism with the severity of multiple sclerosis

References

• Stadelmann C. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr Opin Neurol 2011;24(3):224–9.
   PubMed Web of Science ®Google Scholar
• Dunn SE1, Lee H, Pavri FR, Zhang MA. Sex-based differences in multiple sclerosis (part I): biology of disease incidence. Curr Top Behav Neurosci 2015:1–28 [Epub ahead of print].
   Google Scholar
• Simpson S Jr, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011;82(10):1132–4.
   PubMed Web of Science ®Google Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet 2008;372(9648):1502–17.
   PubMed Web of Science ®Google Scholar
• Sundqvist E, Bäärnhielm M, Alfredsson L, et al. Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet 2010;18(12):1349–52.
   PubMed Web of Science ®Google Scholar
• Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N Engl J Med 1998;339(5):285–91.
   PubMed Web of Science ®Google Scholar
• Smith R, Studd JW. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med 1992;85(10):612–3.
   PubMed Web of Science ®Google Scholar
• Palaszynski KM, Loo KK, Ashouri JF, et al. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 2004;146(1–2):144–52.
   PubMed Web of Science ®Google Scholar
• Mähler A, Steiniger J, Bock M, et al. Is metabolic flexibility altered in multiple sclerosis patients? PLoS One 2012;7(8):e43675. Epub 2012 Aug 28.
   PubMed Web of Science ®Google Scholar
• Oliveira SR, Simão AN, Kallaur AP, et al. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress. Nutrition 2014;30(3):268–73.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–7.
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Triantafyllou N, Papageorgiou C, et al. Associations of the expanded disability status scale with anxiety and depression in multiple sclerosis outpatients. Acta Neurol Scand 2007;115:67–72.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52.
   PubMed Web of Science ®Google Scholar
• Bove R, Musallam A, Healy BC, et al. No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50. BMC Neurol 2013;13:73. doi: 10.1186/1471-2377-13-73
   PubMed Web of Science ®Google Scholar
• Neuteboom RF, Janssens AC, Siepman TA, et al. Pregnancy in multiple sclerosis: clinical and self-report scales. J Neurol 2012;259(2):311–7.
   PubMed Web of Science ®Google Scholar
• Finkelsztejn A, Brooks JB, Paschoal FM Jr, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG. 2011;118(7):790–7. Epub 2011 Mar 15.
   PubMed Web of Science ®Google Scholar
• Finkelsztejn A, Fragoso YD, Ferreira ML, et al. The Brazilian database on pregnancy in multiple sclerosis. Clin Neurol Neurosurg 2011;113(4):277–80.
   PubMed Web of Science ®Google Scholar
• Coyle PK. Pregnancy and multiple sclerosis. Neurol Clin 2012;30(3):877–88.
   PubMed Web of Science ®Google Scholar
• Spence RD, Hamby ME, Umeda E, et al. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 2011;108(21):8867–72.
   PubMed Web of Science ®Google Scholar
• Gold SM, Voskuhl RR. Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 2009;175:239–251.
   PubMed Web of Science ®Google Scholar
• Voskuhl RR, Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 2001;7(3):258–70.
   PubMed Web of Science ®Google Scholar
• Spence RD, Voskuhl RR. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front Neuroendocrinol 2012;33(1):105–15.
   PubMed Web of Science ®Google Scholar
• Airas L, Saraste M, Rinta S, et al. Finnish multiple sclerosis and pregnancy study group. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin Exp Immunol 2008;151(2):235–43.
   PubMed Web of Science ®Google Scholar
• Patas K, Engler JB, Friese MA, Gold SM. Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity. J Reprod Immunol 2013;97(1):140–6.
   PubMed Web of Science ®Google Scholar
• Holmqvist P, Wallberg M, Hammar M, et al. Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 2006;54(2):149–153.
   PubMed Web of Science ®Google Scholar
• Haghmorad D, Amini AA, Mahmoudi MB, et al. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells. J Neuroimmunol 2014;277(1–2):85–95.
   PubMed Web of Science ®Google Scholar
• Lélu K, Delpy L, Robert V, et al. Endogenous estrogens, through estrogen receptor α, constrain autoimmune inflammation in female mice by limiting CD4+ T-cell homing into the CNS. Eur J Immunol 2010;40(12):3489–98.
   PubMed Web of Science ®Google Scholar
• Sicotte NL, Liva SM, Klutch R, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002;52(4):421–8.
   PubMed Web of Science ®Google Scholar
• Bove R, Chitnis T. Sexual disparities in the incidence and course of MS. Clin Immunol 2013;149(2):201–10.
   PubMed Web of Science ®Google Scholar
• Greer JM, McCombe PA. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 2011;234(1–2):7–18.
   PubMed Web of Science ®Google Scholar
• Tomassini V, Onesti E, Mainero C, et al. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 2005;76:272–5.
   PubMed Web of Science ®Google Scholar
• Taylor LC, Puranam K, Gilmore W, et al. 17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss. Neurobiol Dis 2010;39(2):127–37.
   PubMed Web of Science ®Google Scholar
• Dalal M, Kim S, Voskuhl RR. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol 1997;159:3–6.
   PubMed Web of Science ®Google Scholar
• Bove R, Chitnis T. The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis. Mult Scler 2014;20(5):520–6.
   PubMed Web of Science ®Google Scholar
• Bebo BF, Jr., Zelinka-Vincent E, Adamus G, et al. Gonadal hormones influence the immune response to PLP 139–151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 1998;84:122–30.
   PubMed Web of Science ®Google Scholar
• Foster SC, Daniels C, Bourdette DN, Bebo BF, Jr. Dysregulation of the hypothalamic–pituitary–gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroimmunol 2003;140:78–87.
   PubMed Web of Science ®Google Scholar
• Sicotte NL, Giesser BS, Tandon V, et al. Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol 2007; 64(5):683–8.
   PubMed Web of Science ®Google Scholar
• Kurth F, Luders E, Sicotte NL, et al. Neuroprotective effects of testosterone treatment in men with multiple sclerosis. Neuroimage Clin 2014;4:454–60.
   PubMed Web of Science ®Google Scholar
• Wens I, Dalgas U, Deckx N, et al. Does multiple sclerosis affect glucose tolerance? Mult Scler 2013;20(9):1273–6.
   PubMed Web of Science ®Google Scholar
• Mathur D, López-Rodas G, Casanova B, Marti MB. Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis. Front Neurol 2014;5:1–7.
   PubMed Web of Science ®Google Scholar
• Meyer-Moock S, Feng YS, Maeurer M, et al. Systematic literature review and validity evaluation of the expanded disability status scale (EDSS) and the multiple sclerosis functional composite (MSFC) in patients with multiple sclerosis. BMC Neurol 2014;14:58. doi: 10.1186/1471-2377-14-58
   PubMed Web of Science ®Google Scholar